warfarin sodium
- Product NDC
- 58517-360
- 11-digit product format
- 585170360
- Labeler code
- 58517
- Product ID
- 58517-360_f7a32c82-ba7f-4c77-b3b2-f080afee9c6e
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- warfarin sodium
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- New Horizon Rx Group, LLC
- Application
- ANDA040663
- Marketing category
- ANDA
- Marketing start
- 2013-08-25
- Marketing end
- 0000-00-00
- Substance
- WARFARIN SODIUM
- Active strength
- 5 mg/1
- Pharmacologic classes
- Vitamin K Antagonist [EPC],Vitamin K Inhibitors [MoA]
- NDC exclude flag
- E
- Listing certified through
- 2017-12-31
- Current FDA listing
- Historical FDA.report record
NDC auxiliary status#
Explicit status records from FDA unfinished, excluded, and compounder auxiliary files. Absence of a row is not itself a regulatory status.
Dataset, Scope, Product NDC table| Dataset | Scope | Product NDC | Package NDC | Code | Status | Reporting period | Source date |
|---|
| excluded product | product | 58517-360 | | I | Inactivated by FDA | | 2026-07-31 |
| excluded package | package | 58517-360 | 58517-360-30 | I | Inactivated by FDA | | 2026-07-31 |
Orange Book products#
Application-product, Trade name, Ingredient table| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|
| A040663-001 | WARFARIN SODIUM | WARFARIN SODIUM | 1MG | TABLET / ORAL | AB | | 2006-05-30 |
| A040663-002 | WARFARIN SODIUM | WARFARIN SODIUM | 2MG | TABLET / ORAL | AB | | 2006-05-30 |
| A040663-003 | WARFARIN SODIUM | WARFARIN SODIUM | 2.5MG | TABLET / ORAL | AB | | 2006-05-30 |
| A040663-004 | WARFARIN SODIUM | WARFARIN SODIUM | 3MG | TABLET / ORAL | AB | | 2006-05-30 |
| A040663-005 | WARFARIN SODIUM | WARFARIN SODIUM | 4MG | TABLET / ORAL | AB | | 2006-05-30 |
| A040663-006 | WARFARIN SODIUM | WARFARIN SODIUM | 5MG | TABLET / ORAL | AB | | 2006-05-30 |
| A040663-007 | WARFARIN SODIUM | WARFARIN SODIUM | 6MG | TABLET / ORAL | AB | | 2006-05-30 |
| A040663-008 | WARFARIN SODIUM | WARFARIN SODIUM | 7.5MG | TABLET / ORAL | AB | | 2006-05-30 |
| A040663-009 | WARFARIN SODIUM | WARFARIN SODIUM | 10MG | TABLET / ORAL | AB | | 2006-05-30 |
Therapeutic equivalence codes#
DailyMed Product Concepts#
FDA-Initiated Inactive NDC Indexing#
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 58517-360-30 | warfarin sodium | 30 in 1 BOTTLE | TABLET | 30 | | 2 |
DailyMed Socrata Ingredients#
Ingredient, Type, UNII table| Ingredient | Type | UNII | DailyMed label | SPL version | Uploaded |
|---|
| WARFARIN SODIUM | ACTIVE INGREDIENT | 6153CWM0CL | WARFARIN SODIUM TABLET [NEW HORIZON RX GROUP, LLC] | 2 | |
| WARFARIN | ACTIVE MOIETY | 5Q7ZVV76EI | WARFARIN SODIUM TABLET [NEW HORIZON RX GROUP, LLC] | 2 | |
| FD&C YELLOW NO. 6 | INACTIVE INGREDIENT | H77VEI93A8 | WARFARIN SODIUM TABLET [NEW HORIZON RX GROUP, LLC] | 2 | |
| HYDROXYPROPYL CELLULOSE | INACTIVE INGREDIENT | RFW2ET671P | WARFARIN SODIUM TABLET [NEW HORIZON RX GROUP, LLC] | 2 | |
| LACTOSE MONOHYDRATE | INACTIVE INGREDIENT | EWQ57Q8I5X | WARFARIN SODIUM TABLET [NEW HORIZON RX GROUP, LLC] | 2 | |
| MAGNESIUM STEARATE | INACTIVE INGREDIENT | 70097M6I30 | WARFARIN SODIUM TABLET [NEW HORIZON RX GROUP, LLC] | 2 | |
| STARCH, CORN | INACTIVE INGREDIENT | O8232NY3SJ | WARFARIN SODIUM TABLET [NEW HORIZON RX GROUP, LLC] | 2 | |
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 58517-360 | WARFARIN SODIUM TABLET [NEW HORIZON RX GROUP, LLC] | 2 | Legacy NDC, 1 package rows | 20131228_553c6cb0-3ba9-4006-95e5-9c397016253a.zip |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Status |
|---|
| 58517-360-30 | 58517036030 | 30 in 1 BOTTLE | Historical |